Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$17.6
Market cap
$192.5M
P/E Ratio
6.57
Dividend/share
N/A
EPS
$2.68
Enterprise value
$103.58M
Medifast is the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, which offers scientifically developed products, clinically proven plans and the support of Coaches and a
Highlights
The company's quick ratio has surged by 70% YoY and by 7% QoQ
The price to earnings (P/E) is 51% less than the 5-year quarterly average of 13.1 and 9% less than the last 4 quarters average of 7.1
The equity has grown by 11% YoY but it has contracted by 2.7% from the previous quarter
The EPS has dropped by 78% year-on-year and by 57% since the previous quarter
MED's net income has shrunk by 78% YoY and by 57% QoQ
Key stats
What are the main financial stats of MED
Market
Valuations
Earnings
Shares outstanding
10.94M
Market cap
$192.5M
Enterprise value
$103.58M
Price to book (P/B)
0.94
Price to sales (P/S)
0.25
EV/EBIT
3.06
EV/EBITDA
2.02
EV/Sales
0.13
Revenue
$770.18M
EBIT
$33.85M
EBITDA
$51.27M
Free cash flow
$54.4M
Per share
Balance sheet
Liquidity
EPS
$2.68
Free cash flow per share
$4.97
Book value per share
$18.77
Revenue per share
$70.42
TBVPS
$26.84
Total assets
$293.53M
Total liabilities
$88.25M
Debt
$19.1M
Equity
$205.28M
Working capital
$149.14M
Debt to equity
0.09
Current ratio
2.98
Quick ratio
2.17
Net debt/EBITDA
-1.73
Margins
Efficiency
Dividend
EBITDA margin
6.7%
Gross margin
73.9%
Net margin
3.8%
Operating margin
4.4%
Return on assets
9.6%
Return on equity
14.5%
Return on invested capital
24.9%
Return on capital employed
15.5%
Return on sales
4.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MED stock price
How has the Medifast stock price performed over time
Intraday
1.79%
1 week
-2.11%
1 month
-6.38%
1 year
-74.76%
YTD
-73.82%
QTD
-8.05%
Financial performance
How have Medifast's revenue and profit performed over time
Revenue
$770.18M
Gross profit
$569.48M
Operating income
$34.25M
Net income
$29.33M
Gross margin
73.9%
Net margin
3.8%
The operating income has shrunk by 80% YoY and by 58% QoQ
MED's net income has shrunk by 78% YoY and by 57% QoQ
Medifast's operating margin has shrunk by 65% YoY and by 51% QoQ
Medifast's net margin has plunged by 61% YoY and by 49% from the previous quarter
Growth
What is Medifast's growth rate over time
Valuation
What is Medifast stock price valuation
P/E
6.57
P/B
0.94
P/S
0.25
EV/EBIT
3.06
EV/EBITDA
2.02
EV/Sales
0.13
The EPS has dropped by 78% year-on-year and by 57% since the previous quarter
The price to earnings (P/E) is 51% less than the 5-year quarterly average of 13.1 and 9% less than the last 4 quarters average of 7.1
MED's P/B is 90% below its 5-year quarterly average of 9.5 and 66% below its last 4 quarters average of 2.7
The equity has grown by 11% YoY but it has contracted by 2.7% from the previous quarter
The P/S is 81% lower than the 5-year quarterly average of 1.3 and 50% lower than the last 4 quarters average of 0.5
MED's revenue is down by 44% year-on-year and by 14% since the previous quarter
Efficiency
How efficient is Medifast business performance
The return on invested capital has dropped by 85% year-on-year and by 63% since the previous quarter
MED's ROE has shrunk by 82% YoY and by 58% QoQ
The ROA has plunged by 77% YoY and by 56% from the previous quarter
The return on sales has dropped by 65% year-on-year and by 53% since the previous quarter
Dividends
What is MED's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history
Special dividends are included in TTM DPS and yield
Financial health
How did Medifast financials performed over time
The company's quick ratio has surged by 70% YoY and by 7% QoQ
MED's current ratio is up by 50% year-on-year and by 4.9% since the previous quarter
Medifast's debt is 91% less than its equity
Medifast's debt to equity has decreased by 31% YoY and by 10% from the previous quarter
Medifast's debt has decreased by 19% YoY and by 7% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.